Primary Objective: Examine the effect of disease on the responses to meshesSecondary Objective(s):- Compare the acute reaction of macrophages from patients at risk of adverse outcome (obese or aortic aneurysm) after implantation of meshes with theā¦
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
lichaamsvreemde inflammatoire reactie
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
-M1/M2 index
Secondary outcome
- Gene expression of M1 and M2 markers
- DNA levels as indication for the number of cells
Background summary
Foreign body reaction to biomaterials like meshes for hernia repair should be
minimal. A mesh should successfully integrate in the body without causing
massive inflammation and/ or fibrosis. Before a mesh can be used in the clinic,
it is necessary to examine its effect on inflammation and fibrosis. For this,
cell culture and animal experiments are used. In previous studies we have shown
that culturing monocytes isolated from healthy donors on different meshes leads
to a mesh specific reaction and that even in an in vitro model for
contamination, meshes still elicit specific reactions in macrophages.
These two culture models are set-up with cells of healthy donors. It is known
from the clinic however that certain groups of patients have increased risk for
adverse outcomes after implantation of a mesh, such as obese, diabetic, smoking
or old patients and patients with an aortic aneurysm. Age and disease affect
the behavior of cells involved in wound healing and reaction to meshes.
Obesity for instance induces a phenotypic switch in adipose tissue macrophage
polarization, from M2 (macrophages type 2, anti-inflammatory) to M1
(macrophages type 1, pro-inflammatory) activation and obese subjects have more
total fibrosis in white adipose tissue and have more fibrosis around adipocytes
than lean subjects. In addition, recently it was found that macrophages from
obese patients have less differentiation capacity towards an anti-inflammatory
M2 phenotype.
The set-up culture models do not take these diseases into account and it is
expected that cells from obese patients or patients with an aortic aneurysm
will behave differently from cells from healthy subjects in their reaction to
meshes. Therefore, we propose to use macrophages in our earlier set-up models.
The aim if this study is to investigate how disease affects the foreign body
reaction and how cells from patients at risk for adverse outcomes respond to
meshes in vitro. This knowledge can be used to choose the best performing
meshes to be used in specific patient groups. This might eventually lead to a
model that can be used to test several meshes using the patient*s own cells
prior to implantation of a mesh.
Study objective
Primary Objective:
Examine the effect of disease on the responses to meshes
Secondary Objective(s):
- Compare the acute reaction of macrophages from patients at risk of adverse
outcome (obese or aortic aneurysm) after implantation of meshes with the
reaction of macrophages from healthy donors to meshes.
Study design
prospective study
In every group we will include 20 patients.
- 20 patients with BMI >30
- 20 patients with an aortic aneurysm >3cm (BMI between 18-27kg/m2)
- 40 volunteers, control
Study burden and risks
There is no serious extra risk for patients that are participating is this
trial.
Dr Molewaterplein 50
Rotterdam 3015 GE
NL
Dr Molewaterplein 50
Rotterdam 3015 GE
NL
Listed location countries
Age
Inclusion criteria
- Body Mass Index >30 kg/m2 OR aortic aneurysm >3cm OR healthy volunteer
- > 18 years
- signed informed consent
Exclusion criteria
- < 18 years
- BMI< 18kg/m2
- use of the following medication: immunosuppressive drugs, corticosteroids, chemotherapy recently.
- smokers
- Diabetes mellitus type I or II
- Patients who have a medical history like previous surgery or having a prosthesis e.g. heart valve, knee or hip replacement, mesh hernia repair, any kind of osteosynthesis material etcetera, all patients with any foreign body material should be excluded
- Patients who know or think that they might be infected with hepatitis B or C or HIV
- Patients with an autoimmune disease or chronic inflammatory disease.
- Patients who are anaemic or receiving treatment for anaemia or iron deficiency.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL47780.078.14 |